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SUMMARY
Objective: To measure the right and left ventricular thickness in deceased individuals 
with a history of hypertension submitted to clinical autopsies. Methods: We selected 
90 cases from the Death Verification Service of the city of Recife, state of Pernambuco, 
Brazil, of both sexes, with a history of essential arterial hypertension related to heart 
wall thickness, in addition to correlation with autopsy findings and other clinical re-
ports. Results: There was a significant association between the presence of left ventricu-
lar hypertrophy (LVH) and right ventricular hypertrophy (RVH) and between severe 
hypertensive cardiomyopathy and RVH. There was a predominance of RVH and LVH 
in men aged 60-79 years and a higher prevalence in the Brazilian mulatto and Black 
ethnic groups and in those with adequate nutritional status or overweight and obese 
individuals.  Conclusion: It was observed that the presence of RVH was related to LVH, 
suggesting that there are similar pathogenic factors involved in the development of bi-
lateral hypertrophy. The RVH seems to be associated with more severe heart disease and 
may, based on other studies, be considered as a new prognostic factor in the evaluation 
of hypertensive patients.
Keywords: Right ventricular hypertrophy; left ventricular hypertrophy; autopsy; hyper-
tension.
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INTRODUCTION
Systemic arterial hypertension (SAH) is one of the most 
common diseases in our country, and population studies 
have shown a prevalence of 22.3% to 43.9% in Brazil. As-
sessment of SAH becomes relevant due to potential com-
plications, such as cerebrovascular and coronary disease, 
in addition to being responsible for medical and hospital 
costs and substantial socioeconomic burden to society1. 
SAH is one of the causes of left cardiac hypertrophy, 
and the myocardium is the main aected target organ in 
hypertensive individuals2. The increase in peripheral vas-
cular resistance is the determining agent for this adapta-
tion; however, in addition to hemodynamic changes, other 
factors such as neurohormonal activity, cytokines, oxida-
tive stress, ischemia or the expression of genetic factors are 
involved in the development of cardiac remodeling, whose 
main goal is to maintain systolic function3. Left ventricu-
lar hypertrophy (LVH) has been shown to be associated 
with higher cardiovascular risk. Collagen deposition and 
myocardial fibrosis, arrhythmias, diastolic dysfunction, 
and changes in coronary ow may be responsible for in-
creased morbidity and mortality related to this morpho-
logical change4-7.  
In addition to the eects of hypertension on LV, some 
studies have shown that the disease also aects the right 
ventricle (RV)8-10. Many of these evaluations were carried 
out through echocardiographic analysis, particularly the 
study of cardiac mass and volume. In one of these studies, 
Nunez et al. found that the right ventricular wall thickness 
was about two times higher in hypertensive patients with 
left ventricular hypertrophy compared to normotensives 
without hypertrophy9. The observed RV remodeling also 
leads to diastolic dysfunction in both cardiac chambers, 
with decreased ejection fraction and ventricular relaxation 
time to the right. Thus, the observed functional interde-
pendence would occur because the LV and RV share the in-
terventricular septum and form a single structural unit11-13. 
METHODS
The research objectives were focused on the analysis of car-
diac ventricular hypertrophy at clinical autopsy of hyper-
tensive individuals, in order to help clarify its determinant 
factors. Initially, we measured the cardiac wall thickness 
in deceased individuals who had essential hypertension, 
and the results were subsequently correlated. When pres-
ent, left and/or right hypertrophy was classified in grades 
and related to other clinical reports and autopsy findings.  
This was a descriptive, cross-sectional study of 90 
hearts of cadavers from the Death Verification Service of 
Recife – PE (SVO-PE), which were removed for routine 
study and had complete necroscopic examination. The se-
lected age group was 30 years and older, with no upper age 
limit, and both sexes were evaluated.   
The inclusion criterion was a history of essential 
hypertension, using data obtained from relatives and/
or medical-hospital records at the referrals to SVO-PE. 
Exclusion criteria were defined as findings at autopsy or 
clinical report of kidney disease; tumors or vascular or 
endocrine disorders that caused secondary hypertension; 
ischemic heart disease; tumors or infectious valve disease 
that could interfere with the thickness or volume of the 
heart chambers (e.g., acute myocardial infarction and 
dilated cardiomyopathy); idiopathic or acquired pulmo-
nary hypertension; chronic obstructive pulmonary dis-
ease (COPD); recurrent pulmonary thromboembolism 
and autoimmune diseases that could interfere with right 
heart thickness14.
The heart was removed from the mediastinal bed after 
resection of the great vessels and placed in anatomical 
position. The highest-volume section was determined, 
generally coincident with the midpoint between the apex 
of the heart and the left atrioventricular groove. 
At this point, the heart was carefully sectioned 
through a cross-section, exposing the LV, septum, and 
RV. The thickest heart slice was selected and used for 
measurements. A transparent millimeter ruler was used 
to measure the thickness of the anterior, lateral, and 
posterior LV (ALV, LLV, and PLV, respectively) and RV 
(ARV, LRV, and PRV). Endocardial trabeculations, papil-
lary muscle, and epicardial fat were excluded from the 
measures because they are considered data confounders. 
The values  were recorded in adequate file cards, as 
well as data identifying the cadaver (age, race, sex, nu-
tritional status), clinical reports, and other autopsy find-
ings. LV thickness was considered normal up to 1.5 cm15 
and RV thickness up to 0.5 cm8,15. Thus, we defined LV 
hypertrophy (LVH) when the thickness of any of the 
LV walls reached values  above 1.5 cm and RV hypertro-
phy (RVH) when any RV wall was thicker than 0.5 cm.
All deceased individuals with LV hypertrophy 
(LV wall thickness> 1.5 cm) were diagnosed with hy-
pertensive hypertrophic cardiomyopathy (HHC) at the 
autopsy, which is the terminology used when complet-
ing death certificates. The 90 cases were separated into 
groups according to presence or absence of HHC and its 
contribution to death as follows:
Group A – Individuals who died due to HHC, with 
signs of congestive heart failure (polyvisceral congestion, 
acute pulmonary edema);
Group B – Individuals who had HHC associated with 
the immediate cause of death, but not as its primary 
cause;
Group C – Individuals in whom HHC was a minor 
finding at autopsy;
Group D – Absence of HHC (LV wall thickness 
 1.5 cm).
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For data analysis, the absolute and relative distribu-
tions were obtained, as well as measurements of central 
distribution and dispersion. We used the statistical tests of 
chi-square and Fisher’s exact, and the error rate of 5.0% 
was considered.  
The program used for the calculations was the Statis-
tical Package for Social Sciences (SPSS), release 15. The 
study was approved by the Research Ethics Committee  of 
UFPE (registration No. 119/10, on 06/04/10).  
RESULTS
In these 90 cases, the age ranged from 39 to 104 years, with 
mean of 67.5, median of 70.0, and standard deviation of 
15.3 years. The age group of 70-79 years old was the most 
represented, with 27.8% of individuals. A predominance of 
female cases (59.9%), mulattoes (60%), and adequate nu-
tritional status (34.1%) was observed.
There was a predominance of male among indi-
viduals with RVH and LVH in proportional values. 
In women, RVH was observed in 37.7% and LVH in 
64.2% of cases. In men, these values  were 59.5% and 
81.1%, respectively. Women were also assessed ac-
cording to age group (pre- and post-menopausal) and 
presence of ventricular hypertrophy. Up to 49 years 
(n = 6), the percentage of women with LVH and/or RVH 
was 33.4% (n = 2). In women aged 50 years and older 
(n = 47), this value was 72.3% (n = 34). 
The deceased diagnosed with HHC represented by 
Group A accounted for 20% of the total. Group B was the 
most prevalent, with 38.9%. The presence of HHC among 
all groups (A + B + C) was 71.1%. The deceased who did 
not have HHC (Group D) accounted for 28.9% of all cases. 
In the deceased with RVH, a higher prevalence of 
posterior wall involvement was observed (PRV) corre-
sponding to 30% of the total. In descending order, the lat-
eral wall (LRV) was observed in 24.4% and the anterior 
(ARV) in 17.8%. In cases with LVH, the lateral wall was 
the most aected (LLV) in 55.6%, followed by anterior 
(ALV) with 52.2% and posterior (PLV) with 46.7%. It is 
noteworthy that each organ evaluated could display more 
than one LV or RV aected wall.
Hearts exhibiting LV thickness > 1.5 cm and RV > 0.5 cm 
accounted for 44.4% of all cases; the lowest percentage 
found was observed with LV thicknesses  1.5 cm and 
RV > 0.5 cm (2.2%). The dierence revealed a significant 
association (p <0.001) between the presence of LVH and 
RVH. The same percentage of 26.7% was found for de-
ceased individuals with LV> 1.5 and RV  0.5 cm and for 
those with LV  1.5 cm and RV  0.5 cm (Table 1).
Table 2 shows the comparison between groups diag-
nosed with HHC and RV measurements. It was observed 
that the highest prevalence of RV thickness > 0.5 cm was 
found in individuals in Group A (88.9%). This prevalence 
was lower in Group B (54.3%) and Group C (45.5%). 
When there was no HHC, the percentage was 7.7%. The 
observed association between Group A and RVH was 
statistically significant.
There was a higher prevalence of LVH in deceased 
individuals aged 60-69 and 70-79 years (86.7% and 76%) 
of Black or mixed ethnicity (85.7% and 75.9%) and in 
 Evaluation of left ventricle  
Right ventricle LV > 1.5 cm LV  1.5 cm Total group p-value
 n % n % n % 
RV > 0.5 cm 40 44.4 2 2.2 42 46.7 p1 < 0.001*
RV ≤ 0.5 cm 24 26.7 24 26.7 48 53.3  
Total 64 71.1 26 28.8 90 100.0 
* Signiﬁcant difference at the level of 5.0%; 1using Pearson’s chi-square test.
Table 1 – Comparison between right and left ventricular wall thickness
 Evaluation of right ventricle 
Diagnosis of HHC * RV > 0.5 cm RV  0.5 cm Total group p-value
 n % n % n % 
Group A 16 88.9 2 11.1 18 100.0 p1 < 0.001*
Group B 19 54.3 16 45.7 35 100.0  
Group C 5 45.5 6 54.5 11 100.0  
Group D 2 7.7 24 92.3 26 100.0  
Total 42 46.7 48 53.3 90 100.0 
HHC, hypertensive hypertrophic cardiomyopathy (LV > 1.5 cm); Group A, died due to HHC; Group B, associated HHC; however, not a direct cause of 
death; Group C, HHC as minor ﬁnding at autopsy; Group D, absence of HHC (ALV, LLV or PLV ≤ 1.5 cm); * signiﬁcant difference at the level of 5.0%; 
1 using Pearson’s chi-square test.
Table 2 – Right ventricular wall thickness in cadavers, according to the diagnosis of hypertensive hypertrophic cardiomyopathy*
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males (81.1%). In Caucasians, the percentage found was 
62.5%. Regarding nutritional status, obese, overweight 
and normal weight individuals had similar percentages 
(77.8%, 75%, and 76.7%). In underweight individuals, 
however, the finding was 43.7%.
For RVH, the highest prevalence was found in the age 
group of 60-69 years (60%) and in males (59.5%). Among 
the Black, mixed, and Caucasian ethnicities, we observed 
percentages of 57.1%, 46.3% and 45.8%, respectively. As 
for the nutritional status, the highest percentages were 
seen among those with normal weight, overweight, and 
obese (53.3%, 50%, 55.3%). In underweight individuals, 
the prevalence was 25%. Although these percentages of 
LVH and RVH have been shown to be higher among some 
variables of the study, considering the margin of error 
(5%), no significant association was demonstrated. 
The values  found in the LV and RV after measuring the 
thickness of the walls varied as follows: 
t ALV: 1.0-2.1 cm;
t PLV: 0.9-2.0 cm;
t LLV: 1.0-2.4 cm;
t ARV: 0.2-0.7 cm;
t PRV: 0.2-0.7 cm;
t LRV: 0.1-0.7 cm.
The measurements observed in the LV walls (ALV, PLV 
and LLV) were divided into grades:
t Normal: LV thickness up to 1.5 cm; 
t Grade 1: LV thickness from 1.6 to 1.8 cm; 
t Grade 2: LV thickness from 1.9 to 2.1 cm;
t Grade 3: LV thickness from 2.2 to 2.4 cm. 
Once the LV values were graded and compared to 
measurements of the RV wall (ARV, PRV and LRV) and 
the presence or absence of hypertrophy (Table 3), we ob-
served that, as the left ventricular wall became thicker, the 
proportion of cases with RV thickness > 0.5 cm increased. 
This association was statistically significant between the 
degree of hypertrophy of the ALV in relation to the ARV, 
PRV, and LRV. It was also observed in LLV compared 
to PRV. In the remaining walls of LV and RV shown in the 
Table 3, this association was not confirmed for the margin 
of error used (5%).
DISCUSSION
In this evaluation, it was observed that 71.1% of the cas-
es had LVH and received the diagnosis of HHC (Groups 
A + B + C);  this percentage is consistent with the maxi-
mum rates reported in the literature, in which up to 75% 
of hypertensive patients had left ventricular hypertrophy, 
depending on the pressure levels and therapeutic regi-
mens16,17. Among all the deceased individuals that showed 
LVH, 44.4% also exhibited RVH; this was one of the find-
ings with statistical significance observed in this study. 
Significant association was also observed by Gottdiener 
et al. who found RVH in up to 80% of patients who had 
LVH10.
Among the aected walls, there was a predominance 
of hypertrophy in PRV and LLV. The data dier from those 
observed by other authors, among them Cicala et al.18 who 
showed prevalence of hypertrophy in ARV and PLV. 
The mechanisms of right hypertrophy have not been 
fully elucidated, but several factors have been proposed: 
1) There would be transmission of tension experienced 
by the LV to the RV due to the existence of myocardial 
fibers common to both structures, as they share the inter-
ventricular septum and are limited by the pericardial sac; 
2) Neurohumoral factors would mediate ventricular hy-
pertrophy in response to pressure overload in one of them; 
3) As a result of increased volume in the LV, diastolic pres-
sure would increase in the RV; 4) Abnormal emptying of 
the hypertrophic LV, reecting the reduced compliance 
in the disease, would be a determinant of the increased 
volume imposed on the RV, leading to RVH 8-10,12,18-20.  
The presence of LVH and/or RVH was higher in post-
menopausal women, when compared to premenopausal 
women, with this finding being in agreement with those 
reported in the literature. Cardiac hypertrophy is more 
prevalent in menopausal patients, a consequence of the 
decrease in female sex hormones, which are heart pro-
tective3. As the number of premenopausal women in this 
study was reduced (n = 6), despite the suggestion, there is 
insu cient evidence to assess this finding with statistical 
significance.
There was a higher prevalence of LVH in certain vari-
ables (Black or mixed ethnicity, male, and aged 60-79 
years), although not statistically significant. For RVH, the 
highest values  were observed in the deceased aged 60-69 
years and in males. The literature confirms in part the 
findings obtained in this work. There is a higher preva-
lence of hypertension and LVH among men compared 
to the same prevalence in premenopausal women. Left 
hypertrophy is approximately two-fold more prevalent in 
Black patients than in Caucasians, especially when one 
takes into account the foreign series3. It has also been 
observed that it is more frequently diagnosed in elderly 
patients1.
The miscegenation in Brazil makes ethnicity a crite-
rion of lesser validity for assessing the risk of developing 
heart disease21. Although the highest prevalence has been 
observed in Blacks and Brazilian mulattoes with LVH, 
the percentage dierence in comparison to Caucasians 
was small (85.7%, 75.9%, and 62.5%, respectively). For 
RVH, this dierence was even lower (57.1%, 46.3%, and 
45.8%, respectively). In an autopsy study, Lessa et al.22 
also observed that there was no predominance of LVH in 
Black patients evaluated. 
LEFT AND RIGHT VENTRICULAR HYPERTROPHY AT AUTOPSY OF HYPERTENSIVE INDIVIDUALS
45Rev Assoc Med Bras 2012; 58(1):41-47
 ALV
RV wall Normal§ Grade 1§ Grade 2§ Total p-value
Thickness (cm) n % n % n % n % 
ARV         
> 0.5 1 1.5 9 10.0 6 6.7 16 17.8 p1 < 0.001*
≤ 0.5 42 46.7 25 27.8 7 7.8 74 82.2  
PRV         
> 0.5 3 3.3 17 18.9 7 7.8 27 30.0 p1 < 0.001*
≤ 0.5 40 44.4 17 18.9 6 6.7 63 70.0  
LRV         
> 0.5 3 3.3 12 13.3 7 7.8 22 24.4 p1 < 0.001*
≤ 0.5 40 44.4 22 24.4 6 6.7 68 75.6  
Total 43 47.8 34 37.8 13 14.3 90 100.0 
 LLV
RV wall Normal§ Grade 1§ Grade 2§ Grade 3§ Total p-value
Thickness (cm) n % n % n % n % n % 
ARV           
> 0.5 5 5.6 5 5.6 4 4.4 2 2.2 16 17.8 p2 = 0.023*
≤ 0.5 35 38.9 30 33.3 9 10.0 – – 74 82.2  
PRV           
> 0.5 3 3.3 18 20.0 4 4.4 2 2.2 27 30.0 p2 < 0.001*
≤ 0.5 37 41.1 17 18.9 9 10.0 – – 63 70.0  
LRV           
> 0.5 3 3.3 13 14.4 5 5.6 1 1.1 22 24.4 p2 = 0.003*
≤ 0.5 37 41.1 22 24.4 8 8.9 1 1.1 68 75.6  
Total 40 44.4 35 38.9 13 14.4 2 2.2 90 100.0 
 PLV
RV wall Normal§ Grade 1§ Grade 2§ Total p-value
Thickness (cm) n % n % n % n % 
ARV         
> 0.5 8 8.9 6 6.7 2 2.2 16 17.8 p2 = 0.251
≤ 0.5 40 44.4 32 35.6 2 2.2 74 82.2  
PRV         
> 0.5 7 7.8 18 20.0 2 2.2 27 30.0 p2 = 0.002
≤ 0.5 41 45.6 20 22.2 2 2.2 63 70.0  
LRV         
> 0.5 9 10.0 11 12.2 2 2.2 22 24.4 p2 = 0.208
≤ 0.5 39 43.3 27 30.0 2 2.2 68 75.6  
Total 48 53.3 38 42.2 4 4.4 90 100.0 
RV. right ventricle; ARV. anterior right ventricle; PRV. posterior right ventricle; LRV. lateral right ventricle; ALV. anterior left ventricle; LLV. lateral 
left ventricle; PLV. posterior left ventricle. 1 Pearson’s chi-square test; 2 Fisher exact test; § degrees of LV wall thickness: normal – LV up to 1.5 cm. 
grade 1 – LV from 1.6 to 1.8 cm. grade 2 – LV from 1.9 to 2.1 cm. grade 3 – LV from 2.2 to 2.4 cm.
Table 3 – Right ventricle wall thickness (ARV, PRV and LRV) according to the degree of LV wall thickness (ALV, LLV, PLV)
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Obese individuals are certainly more susceptible to de-
veloping hypertension and HHC1,3. Regarding the nutri-
tional status, both cases with LVH and RVH showed to be 
predominant in deceased individuals with normal weight, 
overweight or obese, with no statistically significant dif-
ference between groups and, similarly, when compared 
to underweight individuals. Therefore, we could not state 
such association in this study.
The literature often addresses the inuence of an-
thropometric data and body mass index on cardiac mass, 
particularly in heart weight assessments. Several authors 
consider the physical constitution of the patients (weight 
and height) when interpreting their results23-25. Rodrigues 
stressed in 2006 that all assessments of cardiac mass 
should be adjusted to the values  found in autopsies for the 
population to be studied. They vary with age, sex, ethnic-
ity, body size, and composition26. Salton et al.27, in a study 
using magnetic resonance in a cardiovascular disease-free 
population, observed that the constitution did not inu-
ence only the ventricular mass, but also the volume and 
linear dimensions of the heart. Thus, although this is not 
the assessment of cardiac mass and weight, anthropomet-
ric data that were not obtained in this study should be con-
sidered in further studies. 
Deceased individuals categorized as Group A in the 
diagnosis of HHC (considered as having heart disease of 
poor prognosis, as it was related to congestive heart fail-
ure) had RVH in 88.9% of cases. The observed association 
was significant in statistical tests. Based on these results, 
it is suggested that the presence of RVH is related to more 
severe hypertensive disease. The value of this association 
may indicate the existence of a new prognostic factor for 
the categorization of hypertensive patients.
Regarding the degree of LV wall hypertrophy and its 
association with the presence of RV wall hypertrophy, 
it was observed that the greater the thickness of LV, the 
greater the proportion of cases with RV thickness > 0.5 cm. 
These findings are corroborated by the literature in which 
some authors have observed the same linear association 
between LV wall thickness and presence of RVH9,10,18. 
Despite the higher percentages of RVH according to the 
increased LV walls thickness, there was no statistically 
significant association for all ventricular walls considered 
in the study. This is probably due to the small number of 
cases evaluated. 
STUDY CONCLUSIONS AND LIMITATIONS
Based on the findings of this study, we conclude that RVH is 
associated with a more severe hypertensive disease; there-
fore, it should be taken into account in the routine assess-
ments of hypertensive patients. It may be a new prognostic 
factor, which requires the evaluation of a larger sample to 
be better studied and recognized as such. Another point of 
significance is related to the observed association between 
the presence of LVH and RVH; this finding corroborates the 
theories that postulate common pathogenic factors related 
to the development of bilateral hypertrophic disease.
Due to the lack of more reliable data sources, such as 
medical records, the information reported by family mem-
bers were used. These data are routinely used to complete 
additional information in death certificates (one example 
is the reporting on lifestyle and preexisting conditions, 
such as smoking, alcohol consumption, diabetes mel-
litus). Regarding physical type or nutritional status, the 
categorization of the deceased individuals was obtained 
from reports of autopsies performed by pathologists, cor-
responding to subjective evaluations. As this is a study of 
linear dimensions (thickness) of the cardiac walls, we de-
cided not to assess the weight of the ventricles due to the 
natural di culty in separating the interventricular septum 
between left and right myocardium. Knowing these limita-
tions, it is expected that further work on the subject will be 
able to address them.  
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